Novartis Ag (NVS) Debt to Equity (2017 - 2025)
Novartis Ag (NVS) has disclosed Debt to Equity for 9 consecutive years, with $0.62 as the latest value for Q4 2025.
- Quarterly Debt to Equity rose 24.87% to $0.62 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $0.62 through Dec 2025, up 24.87% year-over-year, with the annual reading at $0.62 for FY2025, 24.87% up from the prior year.
- Debt to Equity hit $0.62 in Q4 2025 for Novartis Ag, up from $0.5 in the prior quarter.
- In the past five years, Debt to Equity ranged from a high of $0.62 in Q4 2025 to a low of $0.41 in Q4 2023.
- Historically, Debt to Equity has averaged $0.48 across 5 years, with a median of $0.44 in 2022.
- Biggest five-year swings in Debt to Equity: surged 102.14% in 2021 and later dropped 7.44% in 2023.
- Year by year, Debt to Equity stood at $0.43 in 2021, then increased by 2.32% to $0.44 in 2022, then dropped by 7.44% to $0.41 in 2023, then rose by 22.33% to $0.5 in 2024, then rose by 24.87% to $0.62 in 2025.
- Business Quant data shows Debt to Equity for NVS at $0.62 in Q4 2025, $0.5 in Q4 2024, and $0.41 in Q4 2023.